Over-the-counter hearing aids are hitting the market, but many consumers may not know what product is best for them. Tuned and Soundly, both hearing care companies, are collaborating to provide guidance.
$265B in care is expected to shift from traditional hospital settings & into patients' homes by 2025. Health systems must prepare for this new care paradigm or risk losing patients to competitors.
By Stephanie Baum Tuesday, October 18, 2022 7:30 AM
The companies exhibiting at HLTH 2022 represent some of the newest and most innovative health tech and reflect a mix of healthcare startups to well-established companies seeking to address some of the biggest challenges and pain points in healthcare.
Inbound Health is a new startup spun out by Minnesota-based Allina Health and Flare Capital Partners. The company is designed to help enable health systems and health plans to establish hospital-at-home and skilled nursing-at-home programs.
By Marissa Plescia Monday, October 17, 2022 7:15 PM
Many Medicare Advantage enrollees choose their plans because they offer more benefits than traditional Medicare and have limits on out-of-pocket costs. Traditional Medicare plans, however, provide more options for doctors, hospitals and providers.
NGM Biosciences' experimental geographic atrophy therapy failed a mid-stage test, making it less likely that drug partner Merck will exercise its option on the antibody. Meanwhile, an Apellis Pharmaceuticals drug for the same disorder is expected to receive an FDA decision by late November.
Eyenuk, a company that makes technology for eye screenings, raised $26 million in a Series A funding round, bringing its total funding to more than $43 million. Research shows that the company's AI system is more accurate in detecting diabetic retinopathy than a clinical examination from a general ophthalmologist or a retina specialist.
Healthcare organizations must ensure they have a data-literate workforce that is confident in using the data and is empowered in using it to make decisions. Here are some best practices that hospitals can implement to better empower their employees to make data-driven decisions.
By Frank Vinluan Monday, October 17, 2022 12:58 PM
Gilead Sciences is betting that a MacroGenics antibody drug for blood cancers can offer a safety edge over others that address the same target. It's the second partnership between the two companies; an alliance that began in 2013 expired without Gilead licensing any molecules from the deal.
By Ahmed Hassan and Erika Glenn Monday, October 17, 2022 8:15 AM
Care management programs are well-positioned to help employers not only improve employee health and manage spend, but recommend needed care or next best steps, and influence behavior changes so adverse health events don't happen in the first place.
Today, the pharmaceutical industry is undergoing a rapid and dynamic transformation. Successful contract management plays an instrumental role in navigating this landscape.
No comments